Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Genetic Technologies Ltd

Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GeneType to Enter Canadian and New Zealand Markets
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Genetic Technologies Expands Operational Capacity in North America
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GeneType and Humanise Health host “Know Your Risk” Event
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Appendix 4C & Quarterly Business Update – March 2024
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Genetic Technologies Announces $2 Million Registered Direct Offering
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GTG to pilot GeneType in Breast Screen centers across the U.S.
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GTG Global Collaborations and Innovation Update
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GTG to launch U.S. Customer Digital Media Sales Campaign
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Launching our most comprehensive test and expanding into new global markets
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV
From Genetic Technologies Ltd
Via GlobeNewswire
Tickers ASX:GTG GENE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.